Highlights
NASDAQ: IDXG       Interpace Diag Grp
Last Price Today's Change   Day's Range   Trading Volume
1.41   -0.08 (5.37%)  1.40 - 1.48  859,700

Overview

 
Avg Volume (4 weeks):2,923,336
4 Weeks Range:1.23 - 1.77
4 Weeks Price Volatility (%):
33.33%
52 Weeks Range:0.07 - 14.25
52 Weeks Price Volatility (%):
9.45%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Interpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.

  Be the first to like this.
 


 

4614  2540  813  431 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 25.02-0.14 
 SPY 249.44+0.05 
 AMD 13.30-0.11 
 AAPL 151.89-1.50 
 DCTH 0.057-0.023 
 ESV 5.24+0.02 
 XLF 25.43-0.03 
 VSAR 2.675-18.925 
 GE 24.87+0.12 
 EEM 45.38-0.26 
Partners & Brokers